Latest News about AKBA
Recent news which mentions AKBA
Why JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 09, 2023
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 09, 2023
From Benzinga
From Benzinga
Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 24, 2023
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 24, 2023
From Benzinga
Why Beyond Meat Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
February 24, 2023
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 23, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 20, 2023
From Benzinga
Why TripAdvisor Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
February 15, 2023
From Benzinga
From InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
February 10, 2023
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 10, 2023
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 02, 2023
From Benzinga
Planned Government Move To Expand Access To Drugs For End-Stage Renal Disease Patients Could Shine The Spotlight On Unicycive
December 07, 2022
From Benzinga
Looking Into Akebia Therapeutics's Return On Capital Employed
November 18, 2022
Tickers
AKBA
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 20, 2022
From Benzinga
Mighty Mitochondria: This Company is Developing A Novel Drug for Kidney Disease By Targeting The Powerhouse Of Human Cells
October 11, 2022
From Benzinga
From Benzinga
Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket
September 27, 2022
From Benzinga
How One Company Plans To Help Battle A Silent Killer Globally Through Its New Kidney Disease Medication
September 22, 2022
From Benzinga
How One Company Plans To Help Battle A Silent Killer Globally Through Its New Kidney Disease Medication
September 22, 2022
From Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
August 05, 2022
From Benzinga
Akebia's Anemia Drug Disappoints In Mid-Stage COVID-19 Study
August 05, 2022
From Benzinga
From Benzinga
From Benzinga
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.